INSULIN C-PEPTIDE INCREASED

This adverse event was reported 139 times

These drugs are most commonly taken by patients reporting INSULIN C-PEPTIDE INCREASED:

# Drug Count
0 METFORMIN 19
1 METFORMIN ER 500 MG 19
2 METFORMIN ER 750 MG 19
3 INSULIN GLARGINE 18
4 ASPIRIN 12
5 ASPIRIN 325 MG 12
6 ASPIRIN 81 MG 12
7 AMLODIPINE 11
8 SITAGLIPTIN 11
9 INSULIN GLARGINE-YFGN 10
See all common drugs associated with INSULIN C-PEPTIDE INCREASED

INSULIN C-PEPTIDE INCREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DIAZOXIDE 1 0.0014
1 CHLORPROMAZINE HYDROCHLORIDE 1 0.0010
2 MIGLITOL 1 0.0010
3 DANTROLENE SODIUM 1 0.0009
4 POTASSIUM ACETATE 1 0.0007
5 GALANTAMINE HYDROBROMIDE 1 0.0006
6 FOSCARBIDOPA/FOSLEVODOPA 4 0.0005
7 INSULIN GLARGINE-YFGN 10 0.0004
8 TRIAMTERENE 3 0.0004
9 INSULIN ASPART INJECTION 1 0.0004
See all drugs enriched for association with INSULIN C-PEPTIDE INCREASED

INSULIN C-PEPTIDE INCREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Potassium-sparing Diuretic [EPC] 3 0.0002
1 alpha-Glucosidase Inhibitor [EPC] 1 0.0002
2 Dipeptidyl Peptidase 4 Inhibitor [EPC] 6 0.0002
3 Phosphodiesterase 3 Inhibitor [EPC] 1 0.0002
4 Sulfonylurea [EPC] 15 0.0001
5 Vitamin K [EPC] 1 0.0001
6 Glinide [EPC] 1 0.0001
7 Insulin [EPC] 4 0.0001
8 Antimycobacterial [EPC] 2 0.0001
9 Melatonin Receptor Agonist [EPC] 1 0.0001
See all drug classes enriched for association with INSULIN C-PEPTIDE INCREASED